Efficacy and Tolerability of Perospirone in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

@article{Kishi2013EfficacyAT,
  title={Efficacy and Tolerability of Perospirone in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
  author={T. Kishi and N. Iwata},
  journal={CNS Drugs},
  year={2013},
  volume={27},
  pages={731-741}
}
BackgroundPerospirone is a second-generation antipsychotic (SGA) used only in Japan, and acts as a serotonin (5-HT)1A receptor partial agonist, 5-HT2A receptor inverse agonist, and dopamine (D)2, D4, and α1-adrenergic receptor antagonist. To our knowledge, no meta-analysis addressing the efficacy and effectiveness of perospirone in schizophrenia has been published to date.ObjectiveThe aim of the study was to identify the characteristics of perospirone by assessing the efficacy, discontinuation… Expand
View on Springer
ncbi.nlm.nih.gov
12 Citations
Background Citations
3
Methods Citations
1
Results Citations
1

12 Citations

Citation Type

Citation Type

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
Cardiometabolic Risks of Blonanserin and Perospirone in the Management of Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Are Second-Generation Antipsychotics Useful in Tardive Dystonia?
Perospirone Exhibits Antiemetic Efficacy against Opioid-Induced Nausea in Patients with Advanced Cancer.
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial
Management of Delirium in Palliative Care: a Review
Antipsychotics and the Dopamine–Serotonin Connection
Antihyperalgesic effects of intrathecal perospirone in a rat model of neuropathic pain
Effects of Repetitive Transcranial Magnetic Stimulation Treatment on Event-Related Potentials in Schizophrenia
Comparing executive functioning and clinical and sociodemographic characteristics of people with schizophrenia who hold a driver’s license to those who do not
...
1
2
...

References

SHOWING 1-10 OF 21 REFERENCES
Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons.
A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients
Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study
A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia.
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol
Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.
Current topics in neuroleptic-induced extrapyramidal symptoms in Japan.
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
...
1
2
3
...